Evidence map›Paper›PMID 18042688›Full record

ReviewJournal of clinical pathology2007

Non-operative breast pathology: apocrine lesions.

C A Wells, G A El-Ayat

Abstract readReview
In one paragraph

Review in Journal of clinical pathology, 2007. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 27 papers.

0numbers the graph read from it
0cells of the map it votes in
27citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

27 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Review
  6. Rare Breast Cancers Review.Healthcare (Basel, Switzerland) · 2024
    Review
  7. Review
  8. Review
  9. Article
  10. Apocrine lesions of the breast.Virchows Archiv : an international journal of pathology · 2022
    Review
  11. Review
  12. MRI Virtual Biopsy of T2 Hyperintense Breast Lesions.Journal of clinical imaging science · 2021
    Article
  13. Article
  14. Article
  15. Review
  16. Article
  17. Article
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

C A WellsSt Bartholomew's Hospital, London, UK. c.a.wells@qmul.ac.uk
G A El-Ayat

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Apocrine metaplasia is a very common finding in the female breast after the age of 25. It is so common that many people regard it as a normal component of the breast. This, however, is only really the case in apocrine sweat glands of the axilla and in the peri-areolar apocrine glands. The apocrine cell does, however, contribute to a number of different breast lesions, some of which are very taxing diagnostically; apocrine variants of both in-situ and invasive cancer are encountered. This review considers the common apocrine metaplastic lesions seen in fibrocystic change as well as apocrine adenoma, apocrine change within sclerosing adenosis, atypical apocrine lesions and apocrine malignancies.

Indexed as

AdenomaApocrine GlandsBiopsyBreastBreast NeoplasmsCarcinoma, Ductal, BreastFemaleFibrocystic Breast DiseaseHumansHyperplasiaMetaplasiaNeoplasm InvasivenessPrecancerous Conditions

Identifiers

PMID18042688
PMCPMC2095572

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.